Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Global Healthy Living Foundation Says Hims & Hers Health Super Bowl ad omits safety risks and side effects of its weight loss ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Independence Blue Cross, a major insurance company, is no longer covering drugs like Zepbound ... letter she received from the insurance company said, "Starting January 1st, 2025, weight loss ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

A tight supply of Novo's semaglutide and Lilly's tirzepatide - sold as Wegovy and Zepbound, respectively, for weight loss - has fueled demand for compounded versions. Median first-month prices ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse ...

ANSWER: “Floaters” are bits of cellular debris in the vitreous humor, which is the gel-filled space in between the lens and ...